PATENT CLAIM ANALYSIS

Application Number: 15990718
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "007600"]

Abstract:
The invention is directed to methods for the treatment of diseases and conditions caused by increased vascular permeability. The invention is also directed to methods for returning vascular permeability that is a symptom of a disease or condition to a homeostatic state. Specifically, the invention is directed to methods for the treatment of diseases and conditions caused by increased vascular permeability or returning vascular permeability that is a symptom of a disease or condition to a homeostatic state by administering to a subject suffering from such diseases and conditions and symptoms novel cellular factor-containing solution compositions (referred to herein as “CFS” compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as “SR-CFS” compositions).

Claim (Index 21):
The method of  claim 16  wherein the ACCS formulated for intranasal administration.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 2.41509
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15492446', '14276140', '12592617', '13653840', '13946022']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7407052688849577
- 35 USC 102 Novelty (BERT): 0.5420697495276641
- Combined Prediction Score: 0.7208417169492283
- Mean Citation Score: 241.23132
- Max Citation Score: 322.9781200000001
- Similarity Product: 134.12249845987802

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test